Goldman Sachs’s ZyVersa Therapeutics ZVSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-296
Closed -$200K 5167
2023
Q1
$200K Buy
296
+112
+61% +$75.6K ﹤0.01% 4523
2022
Q4
$101K Buy
+184
New +$101K ﹤0.01% 4672